toprotecting moisturizer specifically designed for acne-prone skin and acne-affected skin,
and incorporates pharmacologically tested, state-of-the-art ingredients and
technologies that are proven to impart substantial benefits to AV patients.
The efficacy of Cetaphil DermaControl Moisturizer SPF 30 for the enhanced treatment
of AV has been demonstrated by a number of studies evaluating its potential for cutaneous
irritation, comedogenicity, acnegenicity, and photoprotection (Table 1).4
Schorr and colleagues evaluated the benefit of Cetaphil DermaControl Moisturizer
SPF 30 in reducing the side effects associated with topical tretinoin cream.6 The
randomized, investigator/evaluator-blinded, split-face 28-day trial had 174
Kircikhealthy subjects apply tretinoin cream 0.05% once daily to their whole
face and Cetaphil DermaControl Moisturizer SPF 30 to one side of their face.6
The investigators found that approximately 85% of the study’s subjects experienced
skin irritation on both sides of their face, but the skin irritation was predominantly
milder on the side of the face that was treated by Cetaphil DermaControl Moisturizer
SPF 30 (Figure 1).6 The subjects’ tolerability preferences also favored
the Cetaphil DermaControl Moisturizer SPF 30–treated skin (Figure 2).6
Zinc Gluconate
Cetaphil DermaControl Moisturizer SPF 30 contains zinc gluconate. Zinc plays a crucial role in human physiology, and dietary
